Novo Genomics offers comprehensive genomic and multi-omics analysis services to provide personalized health and wellness insights. They make precision medicine accessible through genetic testing, oncology diagnostics, pharmacogenomics, prenatal screening, and rare disease diagnosis. Their offerings support individuals, clinicians, and researchers in improving health outcomes and advancing genomic studies.
Funding
Funding not disclosed
Founders
Product
Problem
Access to advanced genomic and multi-omics analysis for personalized health and wellness solutions is often limited. This restricts the ability to leverage genetic information for early intervention, optimized treatment, and proactive health management.
Solution
Novo Genomics provides a comprehensive suite of genomic and multi-omics services, utilizing advanced analytics and data mining to deliver personalized health and wellness insights. The company focuses on making precision medicine accessible through a range of diagnostic and research support offerings. By analyzing genetic markers and molecular profiles, Novo Genomics aims to improve clinical outcomes and promote proactive health management for individuals and support research initiatives.
Target Audience
Primary customers include individuals seeking personalized health insights, clinicians requiring advanced diagnostics, and researchers involved in genomic and multi-omics studies.
Features
- **Genetic Testing**: Identifies inherited health conditions for early intervention and preventive care.
- **Oncology Diagnostics**: Offers molecular profiling to match cancer patients with personalized treatment options.
- **Pharmacogenomics**: Analyzes genetic markers to prevent adverse drug reactions and optimize therapy selection.
- **Prenatal Screening**: Provides non-invasive tests to assess fetal health and detect potential genetic disorders.
- **Rare Disease Diagnosis**: Employs a proprietary polygenic risk score, developed for the Saudi population, to enhance diagnostic accuracy.
- **Clinical Research Support**: Supplies genomic data and analytics to accelerate clinical and academic research.